| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.02 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.073 | 0.03 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.12 | 0.03 |